The National Institute for Health and Care Excellence (NICE) has announced that the weight-loss injection semaglutide (Wegovy) will be available on the NHS alongside Second Nature and three other digital weight-loss programmes when the pilot project launches
A team of researchers at the University of Bern, Switzerland, recently reported that the use of the antidiabetic medicine semaglutide is associated with an increased risk of vision impairment
On average, patients may expect to pay anywhere from $300 to $1,000 per month
Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushes
Positive framing, such as with the injection example above, can make a lot of difference
Can I take antacids safely with tirzepatide